A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function

Background: Timely detection of graft rejection is an important issue in the follow-up care after solid organ transplantation. Until now, biopsy has been considered the “gold standard” in the diagnosis of graft rejection. However, non-invasive tests such as monitoring the levels of cell-free DNA (cf...

Full description

Saved in:
Bibliographic Details
Main Authors: Adamek, Martina Maria (Author) , Opelz, Gerhard (Author) , Klein, Katrin (Author) , Morath, Christian (Author) , Tran, Thuong Hien (Author)
Format: Article (Journal)
Language:English
Published: 2016
In: Clinical chemistry and laboratory medicine
Year: 2016, Volume: 54, Issue: 7, Pages: 1147-1155
ISSN:1437-4331
DOI:10.1515/cclm-2015-0622
Online Access:Verlag, Volltext: http://dx.doi.org/10.1515/cclm-2015-0622
Verlag, Volltext: https://www.degruyterbrill.com/view/j/cclm.2016.54.issue-7/cclm-2015-0622/cclm-2015-0622.xml
Get full text
Author Notes:Martina Adamek, Gerhard Opelz, Katrin Klein, Christian Morath, Thuong Hien Tran
Description
Summary:Background: Timely detection of graft rejection is an important issue in the follow-up care after solid organ transplantation. Until now, biopsy has been considered the “gold standard” in the diagnosis of graft rejection. However, non-invasive tests such as monitoring the levels of cell-free DNA (cfDNA) as a sensitive biomarker for graft integrity have attracted increasing interest. The rationale of this approach is that a rejected organ will lead to a significant release of donor-derived cfDNA, which can be detected in the serum of the transplant recipient.
Item Description:Gesehen am 20.11.2018
Online erschienen: 17.11.2015
Physical Description:Online Resource
ISSN:1437-4331
DOI:10.1515/cclm-2015-0622